Lucence has made its multicancer early detection test, LucenceINSIGHT, available in Singapore starting 2 March 2026 for as low as S$600 (excluding GST). The LucenceINSIGHT™ Core test covers six common cancers that account for approximately 60% of cancer deaths in Singapore.

• LucenceINSIGHT™ Core (6 Cancers): Screens for thyroid, breast, liver, lung, pancreatic, and colorectal cancers.
• LucenceINSIGHT™ (12 Cancers): Includes breast, gastrointestinal stromal tumour (GIST), lung, bile duct, colorectal, nasopharyngeal, liver, pancreas, cervical, and prostate.
• LucenceINSIGHT™ Plus (50 Cancers): A comprehensive screening for 50 different cancer types.